The policy debates, the clinical studies, the pricing structures — they all orbit the same centre: the patient. But the patient's voice is often the one missing from the room.
Since medical cannabis was legalised in the UK in 2018, an estimated 35,000 to 45,000 people have received private prescriptions. Each of them arrived at that consultation having already tried — and failed — at least two conventional treatments. Their stories follow patterns that anyone in the system will recognise.
Sarah, 42, West Yorkshire: Chronic Pain
Sarah has lived with fibromyalgia for 14 years. Before she approached a cannabis clinic in 2024, she had been prescribed tramadol, pregabalin, amitriptyline, and duloxetine. "Each one either didn't work or made me feel like I wasn't myself," she says. "The tramadol particularly — I was functional but I wasn't present."
She now uses a balanced THC:CBD oil in the evening and a CBD-dominant flower during the day. She hasn't eliminated her conventional medication entirely, but she has reduced her tramadol dose by two-thirds under clinical supervision. "The biggest change isn't the pain level — it's that I can think clearly again. I can read to my children at bedtime and actually remember the story. That stopped years ago."
David, 58, Manchester: Cancer-Related Symptoms
David was diagnosed with prostate cancer in 2023. His treatment — surgery followed by hormone therapy — left him with chronic pain, insomnia, and a loss of appetite that saw his weight drop to a level his oncologist described as concerning. "I was offered more opioids and sleeping tablets. I asked about medical cannabis. My NHS consultant said he couldn't recommend it but wouldn't oppose it."
Six months into treatment with a THC-dominant oil at night and flower for breakthrough pain, David's weight has stabilised, his sleep has improved, and he describes his pain as manageable for the first time since his diagnosis. "I'm not saying it cured my cancer. It didn't. But it made the treatment survivable."
Priya, 31, London: Anxiety and PTSD
Priya accessed medical cannabis through Project Twenty21 in 2025 after a decade of NHS mental health treatment. "I'd done the CBT, the SSRIs, the SNRIs, the talking therapies. Some of it helped. None of it helped enough. I was still having panic attacks at work, still not sleeping, still on edge all the time."
Her clinician prescribed a low-THC, high-CBD oil with a small amount of flower for acute anxiety episodes. "The first month was difficult — I was worried about what people would think, worried about the stigma, worried it wouldn't work. By month three, I was sleeping through the night for the first time in years. I still have bad days. But the baseline is higher. I can function."
The Common Thread
Each of these patients describes the same sequence: years of conventional treatment, partial or no relief, hesitancy about cannabis, and then — cautiously — improvement. None of them describe cannabis as a miracle cure. All of them describe it as the first thing that worked when nothing else did.
There is a gap in UK healthcare, and tens of thousands of patients are filling it with their own money, their own research, and their own courage. Their stories are the data that randomised controlled trials have yet to produce. The evidence base is building. The patients are already here.
